您的位置: 首页 > 农业专利 > 详情页

Nanoparticle-Based Antigen Specific Immunotherapy
专利权人:
Midatech Limited;University College Cardiff Consultants Limited;Nanopass Technologies LTD.;Leiden University Medical Center;Institut National De La Sante et de la Recherche Medicale
发明人:
Martina McAteer,Colin Mark Dayan,James Caradoc Birchall
申请号:
US15561935
公开号:
US20180177891A1
申请日:
2016.04.08
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention provides a nano particle comprising: a core comprising metal atoms; a corona comprising a plurality of ligands covalently linked to the core, wherein said plurality of ligands comprises: at least one carbohydrate ligand; at least one glutathione ligand; and at least one autoantigen peptide ligand. Also provided are compositions and vaccines comprising the nanoparticles, methods for producing the nanoparticles and medical uses of the nanoparticles, including for antigen specific imunotherapy of an autoimmune disease, such as diabetes mellitus type 1, in a mammalian subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充